ReviewEndocrine2024
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons.
Roberta Modica et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ReviewEndocrine2024
Roberta Modica et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.